Document is current
Any future updates will be listed below
-
Authors
Johansen, Joachim https://orcid.org/0000-0001-7052-1870
Atarashi, Koji https://orcid.org/0000-0001-5422-0736
Arai, Yasumichi
Hirose, Nobuyoshi
Sørensen, Søren J. https://orcid.org/0000-0001-6227-9906
Vatanen, Tommi https://orcid.org/0000-0003-0949-1291
Knip, Mikael https://orcid.org/0000-0003-0474-0033
Honda, Kenya https://orcid.org/0000-0001-8937-9835
Xavier, Ramnik J. https://orcid.org/0000-0002-5630-5167
Rasmussen, Simon https://orcid.org/0000-0001-6323-9041
Plichta, Damian R. https://orcid.org/0000-0002-6555-2557
- License Information
-
More Information
Article History
Received: 12 September 2022
Accepted: 23 March 2023
First Online: 15 May 2023
Competing interests
: R.J.X. is a co-founder of Celsius Therapeutics and Jnana Therapeutics, a member of the Scientific Advisory Board of Nestle, and a member of the Board of Directors at Moonlake Immunotherapeutics. These organizations had no role in supporting this study. The other authors declare no competing interests.
